Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis
July 30, 2019 07:30 ET
|
Biogen Inc.
— Diroximel Fumarate Demonstrated Statistically Superior Gastrointestinal (GI) Tolerability on EVOLVE-MS-2 Study’s Primary Endpoint Assessing Self-Reported GI Events — — Discontinuations Due to GI...
EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH
July 22, 2019 10:51 ET
|
LGC Capital LTD.
MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring...
New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis
May 30, 2019 07:30 ET
|
Biogen Inc.
Diroximel fumarate significantly reduced disease activity in newly diagnosed relapsing multiple sclerosis (MS) patients and those previously treated with interferons or glatiramer acetate Data show...
Data at AAN Demonstrate Biogen’s Leadership and Commitment to Innovation in MS
May 07, 2019 07:30 ET
|
Biogen Inc.
Updated results support lower risk of PML with extended interval dosing (EID; approximately every six weeks) for TYSABRI® (natalizumab) in patients in a real-world setting New interim data further...
Adamas Announces Data Presentations at the 71st American Academy of Neurology Annual Meeting
May 06, 2019 21:39 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases
May 01, 2019 07:30 ET
|
Biogen Inc.
Data demonstrate that pre-symptomatic infants with SMA treated with SPINRAZA® (nusinersen) over three years achieved motor milestones that are more consistent with normal childhood...
Longhaulpaul Raises $18,500 for MS Charity on Yamaha Star Venture
April 25, 2019 16:30 ET
|
Yamaha Motor Corp., USA
MARIETTA, Ga., April 25, 2019 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, congratulates Paul Pelland, also known as Longhaulpaul, for setting his third world record by riding a 2018 Yamaha Star...
Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis
February 25, 2019 07:30 ET
|
Biogen Inc.
DUBLIN, Ireland and CAMBRIDGE, Mass., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA)...
Naboso™ Technology Expands Product Line to include the First Commercially Available Textured Insoles and Mats designed to Improve Posture, Balance and Strength through Stimulation of the Feet
January 22, 2019 09:00 ET
|
Naboso Technology
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology, a leading proprioceptive insole and mat company dedicated to revolutionizing the neurological rehabilitation, human performance and...
CES: Smart Footwear brand Digitsole in partnership with the company Zhor-Tech revolutionize medical diagnostics with M-Cube technology
January 09, 2019 16:34 ET
|
Zhor-Tech
Nancy , France, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Digitsole, creating the future of footwear by introducing electronics and software into footwear products, is revolutionizing the medical...